Home
>
National Drug Code (NDC)
>
SEROQUEL
SEROQUEL - 0310-0282-60 - (Quetiapine fumarate)
Drug Information of SEROQUEL
| Product NDC: | 0310-0282 |
| Proprietary Name: | SEROQUEL |
| Non Proprietary Name: | Quetiapine fumarate |
| Active Ingredient(s): | 200 mg/1 & nbsp; Quetiapine fumarate |
| Administration Route(s): | ORAL |
| Dosage Form(s): | TABLET, EXTENDED RELEASE |
| Coding System: | National Drug Codes(NDC) |
Labeler Information of SEROQUEL
| Product NDC: | 0310-0282 |
| Labeler Name: | AstraZeneca Pharmaceuticals LP |
| Product Type: | HUMAN PRESCRIPTION DRUG |
| FDA Application Number: | NDA022047 |
| Marketing Category: | NDA |
| Start Marketing Date: | 20070716 |
Package Information of SEROQUEL
| Package NDC: | 0310-0282-60 |
| Package Description: | 60 TABLET, EXTENDED RELEASE in 1 BOTTLE (0310-0282-60) |
NDC Information of SEROQUEL
| NDC Code | 0310-0282-60 |
| Proprietary Name | SEROQUEL |
| Package Description | 60 TABLET, EXTENDED RELEASE in 1 BOTTLE (0310-0282-60) |
| Product NDC | 0310-0282 |
| Product Type Name | HUMAN PRESCRIPTION DRUG |
| Non Proprietary Name | Quetiapine fumarate |
| Dosage Form Name | TABLET, EXTENDED RELEASE |
| Route Name | ORAL |
| Start Marketing Date | 20070716 |
| Marketing Category Name | NDA |
| Labeler Name | AstraZeneca Pharmaceuticals LP |
| Substance Name | QUETIAPINE FUMARATE |
| Strength Number | 200 |
| Strength Unit | mg/1 |
| Pharmaceutical Classes | Atypical Antipsychotic [EPC] |
